Alpha 2.0
Login Register
» Articles » PMID: 8431220

Appearance of Anti-DNA Antibodies in Patients Treated with Interferon-alpha

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1993 Feb 1
PMID 8431220
Citations 11
Authors
M R Ehrenstein
E McSweeney
M Swane
C P Worman
A H Goldstone
D A Isenberg
Affiliations
Soon will be listed here.
Citing Articles

Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.

Murayama G, Furusawa N, Chiba A, Yamaji K, Tamura N, Miyake S Arthritis Res Ther. 2017; 19(1):234.

PMID: 29052537 PMC: 5649081. DOI: 10.1186/s13075-017-1441-7.

Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis.

Yung S, Cheung K, Zhang Q, Chan T Clin Dev Immunol. 2013; 2013:317682.

PMID: 24171032 PMC: 3793320. DOI: 10.1155/2013/317682.

Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.

Karageorgas T, Tseronis D, Mavragani C J Biomed Biotechnol. 2011; 2011:273907.

PMID: 22162633 PMC: 3227532. DOI: 10.1155/2011/273907.

Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.

Ichikawa H, Conley T, Muchamuel T, Jiang J, Lee S, Owen T Arthritis Rheum. 2011; 64(2):493-503.

PMID: 21905015 PMC: 4584406. DOI: 10.1002/art.33333.

Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.

Yang G, Wan M, Zhang Y, Sun L, Sun R, Hu D Immunology. 2010; 131(4):501-12.

PMID: 20646074 PMC: 2999801. DOI: 10.1111/j.1365-2567.2010.03322.x.